News

Patients Are Left With Few Options as GLP-1 Copycats Disappear
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Healthline2d
First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...
New Atlas2d
Dual-target weight-loss drug is 47% more effective than its rival
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
This Drug Is Nearly 50 Percent More Effective Than Wegovy
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
Lose It! on MSN9d
Should I Take a Supplement If I Am on a GLP-1?
If you experience symptoms like muscle cramping, irregular or fast heart rate, headaches, fatigue, nausea and vomiting, ...
pharmaphorum2d
Digital support reduces GLP-1 dose needed for weight loss
Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...
BioSpace3d
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Becker's Hospital Review13d
CVS Caremark selects Wegovy as preferred GLP-1 for commercial formularies
CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...